Contrast Enhancement Patents (Class 600/458)
  • Patent number: 8043219
    Abstract: Automated determination and setting of an ultrasound system transmit power level is provided for contrast agent imaging. Low mechanical index imaging of contrast agents allows substantially continuous imaging of contrast agents without destruction. By comparing data associated with different transmit power levels and spatial locations, different delays between acquisition or different acquisition sequences, a contrast agent imaging transmit power generally minimizing destruction of contrast agents and maximizing signal-to-noise ratio is automatically determined. By using contrast agent specificity for setting the transmit power in addition or alternative to destruction of contrast agents, harmonic imaging may be improved.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: October 25, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventor: James E. Chomas
  • Patent number: 8036437
    Abstract: An embodiment of a medical imaging system is proposed. The system includes means for providing a sequence of recorded input images each one offering a digital representation at a corresponding instant of a body part being perfused with a contrast agent, each input image including a plurality of visualizing values each one representing a corresponding portion of the body part, and means for associating each sequence of corresponding sets in the input images of at least one visualizing value with a model function of time; the system further includes means for generating a sequence of computed images at further instants, each computed image including a plurality of further visualizing values each one being determined by an instantaneous function-value which is calculated from the associated model function at the corresponding further instant, and means for displaying the sequence of computed images.
    Type: Grant
    Filed: April 13, 2006
    Date of Patent: October 11, 2011
    Assignee: Bracco Research SA
    Inventors: Marcel Arditi, Nicolas Rognin, Peter Frinking
  • Publication number: 20110230765
    Abstract: Destruction for reperfusion in medical diagnostic ultrasound is synchronized to motion. Perfusion data for a volume is acquired sequentially for different segments of the volume. For a given segment, such as a planar region, motion tracking within the segment is performed. If sufficient registration or correlation exists at the completion of a sequence of scans for the current segment, then a lesser amount of movement is occurring. At this point, the transmission of contrast agent destructive acoustic energy is performed in the next segment. Tracking is repeated for the next segment to synchronize the switch to yet another segment. Other regions for tracking can be used. By controlling transmission of destruction pulses, more reliable perfusion quantities in a volume may be determined.
    Type: Application
    Filed: March 17, 2010
    Publication date: September 22, 2011
    Applicant: SIEMENS MEDICAL SOLUTIONS USA, INC.
    Inventor: Ismayil M. Guracar
  • Patent number: 8021303
    Abstract: A perfusion assessment system is proposed.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: September 20, 2011
    Assignee: Bracco Research SA
    Inventors: Peter Frinking, Marcel Arditi, Nicolas Rognin
  • Patent number: 8012092
    Abstract: A combined ultrasound imaging and therapy transducer includes a linear array of imaging transducer elements. First and second linear arrays of therapy transducer elements extend longitudinally along respective first and second sides of the imaging transducer elements and are canted inwardly toward each other. The imaging and therapy transducer is used with an ultrasound imaging system to locate clots in a region of interest. After the region of interest has been perfused with a microbubble contrast agent, the therapy transducer elements are driven by an amplifier located in the transducer to dissolve the clot. The use of the imaging transducer elements and the therapy transducer elements can be interleaved so that the therapy can be conditioned on an ultrasound image showing substantial destruction of the contrast agent microbubbles, re-perfusion of microbubbles in the region of interest, or the continued presence of the clot.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: September 6, 2011
    Assignee: Koninklijke Philips Electronics N.V.
    Inventors: Jeffry E. Powers, John Fraser, Michalakis Averkiou
  • Publication number: 20110208061
    Abstract: An ultrasonic diagnostic imaging system acquires a sequence of image data as a bolus of contrast agent washes into and out of a region of interest (ROI) which may contain a lesion. The image data of contrast intensity is used to compute a time-intensity curve at each point in the ROI. Levels of a time-intensity curve are set to define a rise rime period when contrast perfuses the ROI, an enhancement time period when a maximal amount of contrast is sustained in the ROI, and a fall time period when contrast washes out of the ROI. One or more of the time period parameters for the points in the ROI are used to form a parametric contrast image, which is used to identify a lesion in the ROI and its border.
    Type: Application
    Filed: October 27, 2009
    Publication date: August 25, 2011
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.
    Inventor: Jin Chang
  • Patent number: 7998076
    Abstract: Contrast agents are characterized with ultrasound. Flowing or unbound contrast agents are distinguished automatically from bound or relatively stationary contrast agents. The bound or relatively stationary contrast agents are highlighted on a display. A processor distinguishes different types of contrast agents or contrast agents in different binding states with relative signal strength or velocity. Attached contrast agents are differentiated from phagocytosed contrast agents. Monitoring absolute signal strength as a function of time may indicate binding. Any one or more of these features may be used.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: August 16, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Patrick J. Phillips, James E. Chomas, Ismayil M. Guracar
  • Patent number: 7993273
    Abstract: System parameters for contrast agent medical imaging are conveniently set. A simplified contrast agent configuration is provided where an appropriate contrast agent detection technique and/or contrast agent imaging parameters are achieved consistently and more often then exists with current methods. Examination workflow is improved for contrast agent studies by offering one contrast agent imaging mode or configuration that is dynamically determined and optimized based on the user's selected transmit level and/or a real-time measurement of the contrast agent signals. A simplified user interface provides one contrast agent imaging mode without a need to switch between multiple modes or contrast agent detection techniques and associated contrast agent imaging parameters. The contrast agent detection technique and imaging parameters are adjusting or selected based on changes in the transmit levels for contrast agent imaging.
    Type: Grant
    Filed: May 29, 2008
    Date of Patent: August 9, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Patrick J. Phillips, Ismayil M. Guracar
  • Publication number: 20110190635
    Abstract: The invention relates to an ultrasound scanner comprising a gel distributing device which is attached, or built into, at least one signal emitting probe. The ultrasound scanner is provided with a gel holder for gel used to transmit ultrasound waves for medical, paramedical and/or veterinary procedure purposes. The holder is fixed to the probe and has an opening in the vicinity of the signal emitting or receiving window of the probe. The holder is a tight, sterile, supple pouch, which is tightly connected by tubes or the equivalent to a pump which, in turn, is tightly connected to at least one probe.
    Type: Application
    Filed: January 9, 2009
    Publication date: August 4, 2011
    Inventor: Frédéric Bosler
  • Patent number: 7985183
    Abstract: The difference frequency component between a first fundamental wave of frequency f and a second fundamental wave of frequency f2 is caused to interact with a second harmonic wave, thereby to attain the enhancement of a second harmonic signal, etc., whereby a reflected wave component to be imaged is extracted at a high S/N ratio. By way of example, in a case where the difference frequency component is to appear on the lower frequency side of the second harmonic wave of the first fundamental wave so as to be superposed on this second harmonic wave, the frequencies are set at f2=2.8f or so. Besides, in a case where the difference frequency component is to appear on the higher frequency side of the second harmonic wave of the first fundamental wave so as to be superposed on this second harmonic wave, the frequencies are set at f2=3.2f or so.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: July 26, 2011
    Assignees: Kabushiki Kaisha Toshiba, Toshiba Medical Systems Corporation
    Inventors: Tetsuya Kawagishi, Tomohisa Imamura, Naohisa Kamiyama
  • Patent number: 7981040
    Abstract: A method of ultrasonic detection and localization of contrast agent microbubbles wherein the decision as to whether or not the received ultrasonic signals indicate the presence of a single microbubble or a small microbubble population is made by analyzing the projections of the spectra of said received ultrasonic signals in multidimensional spaces, and by comparing such projections with the projections in said multidimensional spaces of sample control signals corresponding to known conditions of presence and/or absence of single microbubbles and/or small microbubble populations.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: July 19, 2011
    Assignee: ESAOTE, S.p.A.
    Inventors: Andrea Trucco, Daniele Cecchini, Luca Di Resta
  • Patent number: 7981035
    Abstract: In one embodiment, at least one visual characteristic from a selected image is used to automatically select an ultrasound image from a set of images from a plurality of heart cycles. In another embodiment, motion correction is performed on ultrasound images that are automatically selected from a plurality of ultrasound images associated with the same phase of the heart cycle. In yet another embodiment, ultrasound images are automatically selected from a set of images based on a time interval that is within a tolerance range from a reference phase of the heart cycle. In another embodiment, a stored user-preference of a phase of the heart cycle is used to automatically select an ultrasound image from a set of images. In yet another embodiment, a user-defined region of interest is placed on an ultrasound image associated with a selected phase of a heart cycle.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: July 19, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Edward A. Gardner, Michael N. Woelmer
  • Patent number: 7967753
    Abstract: Provided herein are Pulse-Inversion (PI) sequences that provide for fundamental frequency suppression in nonlinear imaging applications. In an embodiment, a weighting scheme is applied to the received echo pulses resulting from transmit pulses of alternating polarity to reduce the effect of transducer motion. In an embodiment, a three-pulse weighting scheme is applied to a PI sequence. In other embodiments, different combinations of the three-pulse weighting scheme are applied to a PI sequence.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: June 28, 2011
    Assignee: Stichting Voor de Technische Wetenschappen of Van Vollenhovenlaan
    Inventors: Martijn Egbert Frijlink, David Eric Goertz, Antonius Franciscus Wilhelmus van der Steen
  • Patent number: 7955265
    Abstract: Methods, apparatus and systems for measuring a thickness of a portion of a multi-layer vessel based on at least one medical diagnostic image frame using an integrated ultrasound device is provided. The method includes for each x-coordinate determining a y-coordinate along an interface between each layer of the vessel including determining a Y coordinate of a center of an intima-media center (IMC) determining the adventitia-media interface Y coordinate, determining the intima-lumen interface Y coordinate, determining for each X coordinate the lumen-intima interface Y coordinate, determining media-adventitia interface Y coordinate, determining a thickness of at least one vessel layer using X and Y coordinates of respective layer interfaces, and outputting the thickness to a display.
    Type: Grant
    Filed: August 15, 2005
    Date of Patent: June 7, 2011
    Assignee: General Electric Company
    Inventors: Elina Burla, Doron Hess, Alexander Sokulin
  • Patent number: 7946988
    Abstract: Contrast agent destruction transmissions have reduced biological effect in medical diagnostic ultrasound. Ramping-up amplitude and/or ramping-down frequency reduce biological effect. The amplitude ramps up linearly or non-linearly. The change in amplitude or frequency occurs over a single waveform or over a sequence of separate transmissions. An envelope of the single waveform or the sequence of separate transmissions has a non-uniform, asymmetrical, symmetrical, rectangular or other shape. For example, the frequency ramp-down is provided with a non-Gaussian envelope. The amplitude ramp-up or frequency ramp-down is a progressively increasing destructive characteristic or ability, destroying contrast agent at different regions relative to focal regions with a minimum of acoustic energy.
    Type: Grant
    Filed: December 13, 2005
    Date of Patent: May 24, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Anming He Cai, Lewis J. Thomas
  • Patent number: 7931595
    Abstract: The invention relates to a triggered ultrasound imaging method for imaging of the myocardium, minimizing the risk of eliciting cardiac arrhythmia. Particularly, the invention is directed to a method of assessing cardiac perfusion. Destruction pulses are triggered such that they fall within the refractory period of the heart, while imaging pulses are triggered at any given time of the ECG cycle, preferably during end-systole.
    Type: Grant
    Filed: November 27, 2003
    Date of Patent: April 26, 2011
    Assignee: GE Healthcare AS
    Inventors: Ragnar Bendiksen, Henrik Rasmussen, Jonny Ostensen
  • Patent number: 7925056
    Abstract: A method for investigating and ascertaining pulse or heartbeat includes directing illuminating radiation to illuminate a body part such as a finger. The illuminating radiation is of a wavelength or wavelength band substantially in the blue light region of the light spectrum. Then, an optical speckle pattern of the illuminated body part resulting from the illumination of the body part is obtained and imaged. The optical speckle pattern is representative of the heartbeat and by correlation of frames extracted from the speckle pattern, the pulse or beat extent of the body part may be ascertained.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: April 12, 2011
    Assignee: Koninklijke Philips Electronics N.V.
    Inventors: Cristian Presura, Coen Theodorus Hubertus Fransiscus Liedenbaum, Antonius Hermanus Maria Akkermans
  • Publication number: 20110082374
    Abstract: A method and system for quantifying the extent of vaso vasorum with contrast enhanced ultrasound and correlating that quantitative value to the risk for vascular disease is provided. An ultrasound contrast agent is administered to a subject and images are obtained using an imaging method that identifies the uptake of the contrast agent by tissues. The amount of uptake is measured and the corresponding signal intensity change correlated with the amount of vaso vasorum present. Additionally, deformations of the vasculature are measured from the series of ultrasound images and this information is coupled with the quantification of the vaso vasorum to determine a risk index indicative of a subject's risk to vascular disease.
    Type: Application
    Filed: June 10, 2010
    Publication date: April 7, 2011
    Inventors: Joan C. Main, Bijoy K. Khandheria, A Jamil Tajik, Robert T Hurst, Steven J Lester, Christopher B Kendall, Susan Wilansky
  • Publication number: 20110077524
    Abstract: Ultrasonic diagnostic arrangements (apparatus, methods, etc.) including: an ultrasonic probe or operation for transmitting an ultrasonic wave to an object to be tested and receiving an ultrasonic wave from the object; a transmitter or operation for pulse-driving the ultrasonic probe to transmit an ultrasonic beam to the object; a reception phasing unit or operation for performing phasing on reflected echo signals received by the ultrasonic probe, the reception phasing unit separately performing phasing at multiple phasing frequencies on the reflected echo signals received in response to at least one transmission of the ultrasonic beam; an image generator or operation for generating an ultrasonic image based on the phased received signal.
    Type: Application
    Filed: May 20, 2009
    Publication date: March 31, 2011
    Inventors: Mitsuhiro Oshiki, Hiroshi Masuzawa
  • Patent number: 7892522
    Abstract: Ultrasound contrast agents comprising microbubbles of biocompatible gas, e.g. a sulphur halide or a perfluorocarbon, stabilized by opsonisable amphiphilic material, e.g. a membrane-forming lipid such as a phospholipid, especially a negatively charged phospholipid such as a phosphatidylserine, may exhibit prolonged contrast-generating residence time in the liver following intravenous administration.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: February 22, 2011
    Assignee: GE Healthcare AS
    Inventors: David Johnson, Jonny Østensen, Morten Eriksen, Audun Tornes, Sigmund Frigstad, Harald Dugstad, Jo Klaveness, Pål Rongved, Roald Skurtveit, Jorunn Brænden
  • Patent number: 7887486
    Abstract: Adaptive grating lobe suppression is provided. Received ultrasound data is measured, compared or otherwise processed to determine the presence of grating lobe energy. A further process is then altered as a function of the level of grating lobe energy. In one embodiment, the adaptive grating lobe suppression is implemented in the receive beamformer. Data representing a virtual element is formed as a normalized sum of data from adjacent sparse elements. The data from the adjacent elements is correlated to determine the presence of grating lobe energy as a function of the amount of shift associated with the peak correlation. A phase shift is applied to the data representing the virtual element where sufficient grating lobe energy is determined. In another embodiment, an amount of grating lobe energy is measured by comparing data from prior to a filter with filtered data. The filter is selected to isolate main lobe energy from grating lobe energy.
    Type: Grant
    Filed: March 14, 2007
    Date of Patent: February 15, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Kutay F. Ustuner, Albert Gee
  • Patent number: 7876149
    Abstract: Disclosed herein is a harmonic quadrature demodulation apparatus and method. The harmonic quadrature demodulation apparatus includes an input terminal for externally receiving an input focused signal, a harmonic phase estimation unit for estimating a second-order harmonic phase component from the input focused signal. The second-order harmonic detection unit includes an in-phase component extractor, a quadrature component extratctor, a Hilbert transformer, an adder and a low pass filter. The in-phase component extractor extracts an in-phase component of the input focused signal. The quadrature component extractor extracts a quadrature component of the input focused signal.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: January 25, 2011
    Assignee: Industry-University Cooperation Foundation Sogang University
    Inventors: Tai-Kyong Song, Sang-Min Kim, Jae-Hee Song
  • Patent number: 7867166
    Abstract: In estimation of an aberration in propagation of an ultrasonic wave from an aperture through an aberration path, the aperture is modeled as a plurality of sources and receivers. The frequency-domain magnitude of the aberration is estimated by normalizing the scattered signal power spectrum. The frequency-domain phase of the aberration is estimated by a recursion using cross spectra of signals at neighboring receivers.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: January 11, 2011
    Assignee: University of Rochester
    Inventors: Robert C. Waag, Jeffrey P. Astheimer
  • Patent number: 7862511
    Abstract: A method of generating three-dimensional (3D) full volume ultra-sound images with the uses of contrast agents includes acquiring ultrasound image data for multiple subvolumes (140,142,144,146) synchronized to an ECG (100) over multiple cardiac cycles (124,126,128,130) via triggering (104,114,106,116,108,118,110,120). Acquiring includes at least one of two acquisition protocols. The first acquisition protocol uses an output acoustic power insufficient for causing destruction of the contrast agents during ultrasound image data acquisition (10). The second acquisition protocol uses an output acoustic power sufficient for causing destruction of the contrast agents during ultrasound image data acquisition (10). Triggering (26,28) of respective ones of the ultrasound image data acquisitions of the multiple subvolumes (140,142,144,146) is selected to enable destroyed contrast agents to be replaced by new contrast agents prior to a subsequent triggering of ultrasound image data acquisition of a subsequent subvolume.
    Type: Grant
    Filed: October 14, 2004
    Date of Patent: January 4, 2011
    Assignee: Koninkliljke Philips Electronics N.V.
    Inventor: Patrick G. Rafter
  • Patent number: 7850612
    Abstract: An ultrasonic enhanced-contrast imager and method includes an ultrasonic probe for transmitting and receiving an ultrasonic wave to and from an organism, a transmitting section for transmitting an ultrasonic signal to the ultrasonic probe, a receiving section for processing a response signal ultrasonic wave received by the ultrasonic probe, a filter for extracting a specific frequency component from the processed response signal, and a setting control section for setting a pass frequency band of the filter on the basis of a frequency band of the response signal from a contrast medium injected to the organism. A control section controls the operation of the filter in the set pass band, and the setting control section sets the center frequency of the pass band of the filter to be greater than f0 and less than 2f0, where f0 is the average frequency of the ultrasonic signal transmitted to the ultrasonic probe.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: December 14, 2010
    Assignee: Hitachi Medical Corporation
    Inventors: Hiroshi Kanda, Tatsuya Hayashi, Tsuyoshi Mitake, Minoru Yoshida
  • Publication number: 20100312117
    Abstract: An invasive medical device includes a fluid path of microbubbles which is imaged by ultrasound during use of the device. The fluid path extends through the device, preferably to the distal end of the device, so that the diffuse reflection of ultrasound from the microbubbles can be received to image the location of the device. The fluid path can be open, terminating at the tip of the device, or can be a closed path of a circulating microbubble fluid used for imaging and/or cooling.
    Type: Application
    Filed: November 18, 2008
    Publication date: December 9, 2010
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.
    Inventors: Anna Fernandez, Hua Xie, Christopher Hall, Shunmugavelu Sokka, Thomas Gauthier
  • Publication number: 20100312118
    Abstract: Systems and methods for enhancing diagnostic imaging by the means of increasing tissue perfusion and/or vasodilation, and thus, increasing imaging agent perfusion distribution and/or imaging agent uptake by tissue. The desired effects can be achieved by exposing the area of interest to ultrasound either before or after image acquisition, or in between multiple image acquisitions.
    Type: Application
    Filed: May 18, 2010
    Publication date: December 9, 2010
    Inventor: Michael J. Horzewski
  • Patent number: 7846098
    Abstract: Methods and systems are provided for automatic optimization for ultrasound medical imaging. In one approach, velocity values are unwrapped to avoid aliasing artifacts. Multi-dimensional phase unwrapping is applied to the velocity data. The unwrapped velocity information is used to optimize one or both of the velocity scale (e.g., pulse repetition frequency) and the imaging frequency. For optimizing the scale setting, the distribution of unwrapped velocities from a systolic time period of the heart cycle are used to identify the pulse repetition frequency. For optimizing the imaging frequency, a correlation as a function of depth shows the penetration depth for a given imaging frequency. In a dependent or independent approach, one or more thresholds for velocity or energy in flow imaging are adaptively selected as a function of an amount of clutter. Velocity or other energy information in addition to the clutter information may be used for selecting the thresholds.
    Type: Grant
    Filed: August 13, 2007
    Date of Patent: December 7, 2010
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Mü{umlaut over ( )}ge M. Bakircioglu, Robert W. Steins, Constantine Simopoulos
  • Patent number: 7846100
    Abstract: A medical imaging system is proposed.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: December 7, 2010
    Assignee: Bracco International BV
    Inventors: Emmanuel Gaud, Peter Frinking, Nicolas Rognin, Sibylle Pochon, Nathalie Biolluz, Marcel Arditi
  • Publication number: 20100298710
    Abstract: An ultrasonic imaging apparatus and method are described for monitoring the progress of therapy for pathology such as lesions, tumors, and metastases by means of contrast agent imaging. A sequence of images are acquired as a bolus of contrast agent infuses the tissue containing the pathology. A contrast wash-in time parameter is calculated for both the tumor and normal tissue, and a ratio is calculated of the two wash-in time parameters (called WITR) which removes the effects of variations in the procedure from one therapy monitoring session to another. A difference curve of the time-intensity curves of the pathology and normal tissue is also produced, which is similarly immune to procedural variations. The motional effects of respiration can be taken into account by detecting the position of a landmark such as the diaphragm in each of the images of the sequence and discarding from processing those which exhibit a change in the position of the landmark relative to the probe.
    Type: Application
    Filed: January 23, 2009
    Publication date: November 25, 2010
    Applicant: Koninklijke Philips Electronics N.V.
    Inventors: Michalakis Averkiou, Marios Lampaskis, Konstantina Kyriakopoulou
  • Publication number: 20100298709
    Abstract: This invention employs multiple ultrasound pulse firings of either alternating phase and/or amplitude to detect nonlinear fundamental and subharmonic signals from microbubble contrast agents within living tissue, at high frequencies (?15 MHz), e.g., with a linear array transducer. It can be shown that the contrast-to-tissue ratio (CTR) decreases with increasing ultrasound frequency because of nonlinear ultrasound propagation in tissue. However, using the subharmonic signal in addition to the nonlinear fundamental harmonic component, rather than the conventional second harmonic used at lower frequencies, provides appreciable signal strength to overcome the limitations of nonlinear tissue propagation. Additionally, the method provides for the ability to switch, at some desired frequency above 20 MHz, into a purely alternating phase inversion acquisition, in combination with bandpass filtering of the subharmonic frequency band, minimizing the losses in CTR as the frequency increases.
    Type: Application
    Filed: April 19, 2010
    Publication date: November 25, 2010
    Applicant: VisualSonics Inc.
    Inventors: Andrew Needles, James I. Mehi, Desmond Hirson
  • Patent number: 7837626
    Abstract: Contrast agents are manipulated with acoustic radiation force while ultrasound imaging. Continuous waves for acoustic radiation force are transmitted. Substantially simultaneously, pulsed waves for imaging are transmitted. Low mechanical index continuous and pulsed waves may be used to increase binding efficiency of drug containing contrast agents with the tissue for treatment. Various techniques may be used to minimize the effect of the continuous waves on imaging with the pulsed waves. The acoustic radiation force may be transmitted with an amplitude profile and/or unfocused or defocused.
    Type: Grant
    Filed: August 5, 2005
    Date of Patent: November 23, 2010
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: James E. Chomas, Ismayil M. Guracar, Patrick J. Phillips, John D. Marshall
  • Patent number: 7826883
    Abstract: A localization mechanism, or fixture, is used in conjunction with a breast coil for breast compression and for guiding a core biopsy instrument during prone stereotactic biopsy procedures in both open and closed Magnetic Resonance Imaging (MRI) machines. The localization fixture includes a fiducial marker and three-dimensional Cartesian positionable guide for supporting and orienting an MRI-compatible biopsy instrument with detachable probe/thumb wheel probe to the biopsy site of suspicious tissues or lesions.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: November 2, 2010
    Assignee: Devicor Medical Products, Inc.
    Inventors: John A. Hibner, Gary Todd McCollister, David Denis Beck, David Scott Little
  • Publication number: 20100274135
    Abstract: A method of detecting at least one axillary sentinel lymph node using ultrasonography is described. The method comprises injecting an iron hydroxide compound into a patient at or near a suspected tumor site in the breast and waiting an amount of time required for the iron hydroxide compound to enter cells of the sentinel lymph node. The axillary area near the injection site may then be analyzed using ultrasonography to identify at least one sentinel lymph node. Once identified, a small sample of tissue from the identified sentinel lymph node may be taken for pathological analysis to aid in determination of the stage or extent of breast cancer.
    Type: Application
    Filed: April 23, 2010
    Publication date: October 28, 2010
    Applicant: CAMC HEALTH EDUCATION AND RESEARCH INSTITUTE, INC.
    Inventor: Roberto Kusminsky
  • Publication number: 20100256495
    Abstract: A method (50) for quantitative 3D contrast enhanced ultrasound (CEUS) analysis includes acquiring (54) an initial pair of ultrasound contrast and tissue images of an anatomy. A region of interest (ROI) or volume of interest (VOI) is established (56) in the initial acquired tissue image, which becomes the baseline tissue image. The established ROI/VOI is automatically registered (58) from the initial tissue image to the initial contrast image, which becomes a baseline contrast image. Quantitative analysis is performed (60) on the ROI/VOI of the baseline contrast image. The method further includes acquiring (62) a next ultrasound contrast and tissue image pair, corresponding to an i th current contrast and tissue image pair.
    Type: Application
    Filed: November 5, 2008
    Publication date: October 7, 2010
    Applicant: KONINKLIJKE PHILIPS ELECTRONICS N.V.
    Inventors: Jochen Kruecker, Sheng Xu
  • Patent number: 7803115
    Abstract: A method for measuring a non-linear response from a target using an imaging apparatus includes transmitting a signal towards a region of interest from a transducer at a first amplitude and measuring a first response thereto, and transmitting, from the transducer towards the region of interest, at least one additional signal of the same phase as the first amplitude signal but at one or more different, lower amplitudes and measuring at least one additional response thereto. A difference of a function of the measured additional response or responses from the first response is determined, thereby obtaining a non-linear response of the object of interest, and a representation of the non-linear response is displayed.
    Type: Grant
    Filed: July 16, 2007
    Date of Patent: September 28, 2010
    Assignee: General Electric Company
    Inventors: Lihong Pan, Michael Joseph Washburn, Kirstin Nora LaConte
  • Publication number: 20100241001
    Abstract: Ultrasound systems for identifying a presence of injected fluid in a region of interest are provided. The ultrasound system includes a controller configured to obtain first and second image data sets of a region of interest from an ultrasound transducer array. A decorrelation module is configured to identify a decorrelation region of decorrelated data that is decorrelated between the first and second image data sets. The decorrelation region indicates a presence of injected fluid in the region of interest.
    Type: Application
    Filed: March 20, 2009
    Publication date: September 23, 2010
    Inventors: Mark L. Palmeri, David B. MacLeod, Jeremy J. Dahl, Stuart A. Grant, Kathryn R. Nightingale
  • Patent number: 7799022
    Abstract: Tissue ablation probes are provided. Each tissue ablation probe comprises an electrically conductive probe shaft, at least one tissue ablation electrode carried by a distal end of the probe shaft, and an electrically insulative outer sheath disposed on the probe shaft. The sheath is at least partially composed of polyether ether ketone (PEEK) and another material comprising condensed-phase particles interspersed throughout the PEEK to increase the echogenicity of the outer sheath. The durability of the PEEK allows the sheath to be formed as thinly as possible, thereby minimizing the diameter of the ablation probe, while the inclusion of condensed-phase particles within the PEEK does not significantly degrade the durability of the sheath.
    Type: Grant
    Filed: July 6, 2006
    Date of Patent: September 21, 2010
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Kathleen Fernald, Robert F. Rioux
  • Patent number: 7798967
    Abstract: In an ultrasound diagnosis apparatus, a plurality of sub arrays are defined on a 2D array transducer. A plurality of groups are defined for each sub array. Each group is basically composed of a plurality of transducer elements which are connected in parallel with each other. A sub array shape is variably defined for a plurality of sub arrays in accordance with the beam direction and the depth of a focal point. Further, a grouping pattern is variably defined for each sub array. The acoustic distances between the respective transducer elements and the focal point is made as equal as possible for a plurality of transducer elements forming each group, whereby a preferable beam profile can be obtained.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: September 21, 2010
    Assignee: Aloka Co., Ltd.
    Inventor: Hideki Takeuchi
  • Patent number: 7792569
    Abstract: The invention provides materials, devices and methods for marking biopsy sites for a limited time. The biopsy-marking materials are ultrasound-detectable bio-resorbable powders, with powder particles typically between about 20 microns and about 800 microns in maximum dimension, more preferably between about 300 microns and about 500 microns. The powders may be formed of polymeric materials containing cavities sized between about 10 microns and about 500 microns, and may also contain binding agents, anesthetic agents, hemostatic agents, and radiopaque markers. Devices for delivering the powders include tubes configured to contain the powders and to fit within a biopsy cannula, the powders being ejected by action of a syringe. Systems may include a tube containing powder, and a syringe containing sterile saline. The tube may be configured to fit within a biopsy cannula such as a Mammotome® or SenoCor 360™ cannula.
    Type: Grant
    Filed: November 16, 2004
    Date of Patent: September 7, 2010
    Assignee: SenoRx, Inc.
    Inventors: Fred H. Burbank, Paul Lubock, Michael L. Jones
  • Patent number: 7789831
    Abstract: Using configurable arrays, synthetic aperture processes may be used along an elevation dimension for increasing resolution. The increased resolution is used for two-dimensional or three-dimensional imaging. Alternatively or additionally, wide band synthetic elevation aperture focusing processes, such as beamformation, are provided along the elevation dimension to increase resolution. In yet another alternative or additional embodiment, a transducer is rotated about a center of the transducer within the elevation and azimuth plane. An aperture associated with the transducer is mechanically or electronically rotated, and ultrasound data acquired associated with a plurality of different positions. The ultrasound data is then used for synthetic elevation aperture processing. In yet another alternative or additional embodiment, multiple scanning modes are provided. In a survey mode, imaging is provided without synthetic elevation aperture processing.
    Type: Grant
    Filed: March 9, 2007
    Date of Patent: September 7, 2010
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Stephen R. Barnes, Mirsaid Bolorforosh, D-L Donald Liu
  • Patent number: 7785260
    Abstract: An ultrasonograph capable of generating a transmission beam comprising a main beam having a uniform width over a wide range in an ultrasonic wave propagation direction by one-time transmission of an ultrasonic pulse. A weighted mean value of a plurality of transmission delay time values corresponding to focal lengths of transmission pulse waves having a plurality of focal points which are set in the ultrasonic wave propagation direction is calculated for each of elements constituting a transmission aperture and used as the delay time. The curvature of a transmitted wave front is close to a short focal length in the center portion of the transmit aperture and is close to a long focal length in the peripheral portion. Thus, a transmission beam including a relatively narrow main beam with a uniform width over a wide range in the ultrasonic wave propagation direction can be generated.
    Type: Grant
    Filed: June 5, 2002
    Date of Patent: August 31, 2010
    Assignee: Hitachi Medical Corporation
    Inventors: Shin-ichiro Umemura, Yuichi Miwa, Takashi Azuma, Takashi Sugiyama, Hiroshi Kuribara
  • Patent number: 7780602
    Abstract: Methods and system for controlling an ultrasound system are described. One method includes acquiring ultrasound data relating to an object and iteratively adjusting acoustic power output of the ultrasound system based on the acquired ultrasound data.
    Type: Grant
    Filed: December 27, 2004
    Date of Patent: August 24, 2010
    Assignee: General Electric Company
    Inventors: Xiaohui Hao, Kirstin Nora LaConte
  • Patent number: 7778454
    Abstract: At least one embodiment of the present application relates to a method and/or an apparatus for determining the concentration of a substance in a body material that is composed of two different material components in an unknown ratio. In an embodiment of the method, two computed tomography pictures from which two image data records are reconstructed are recorded in conjunction with two different spectral distributions of the x-radiation. The x-ray attenuation values for each voxel of the two image data records are decomposed into three material components. The decomposition is performed on the assumption that the x-ray attenuation value xM of the body material without the substance is composed of the x-ray attenuation values xM1, xM2 of the first and second material component in accordance with the following equation: xM=f*xM1+(1-f)*XM2, f being a volume fraction of the first material component in the body material.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: August 17, 2010
    Assignee: Siemens Aktiengesellschaft
    Inventors: Michael Grasruck, Bernhard Krauss
  • Patent number: 7775981
    Abstract: A transmit sequence for contrast agent imaging that improves sensitivity and minimizes image artifacts. The number of pulses and the interleaving of spatially distinct pulses between spatially co-linear pulses are selected such that a substantially similar pulse sequence for substantially each line in a scanned region is generated. A collateral pulse from a different scan line is interleaved between at least two imaging pulses along a scan line of interest. Such pulse sequences provide sensitive contrast agent imaging with minimized spatial variation. In another aspect, responsive signals representing the first and second scan lines are obtained. Intensities associated with the signals are determined. The intensities associated with the first scan line are compared to a value.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: August 17, 2010
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Ismayil M. Guracar, Patrick J. Phillips
  • Patent number: 7771359
    Abstract: A two step method of enhancing the cavitational effect produced by ultrasonic signals focused at a specific location in a medium includes a first step of using one or more transducers to apply the ultrasonic signals to create a waveform that causes formation of bubbles at the location, and a second step of modulating the amplitude of the ultrasonic signals at a frequency of several Hz to several tens of kilohertz immediately following or coincident with the formation of the bubbles.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: August 10, 2010
    Assignee: Venousonics Ltd.
    Inventor: Dan Adam
  • Patent number: 7753850
    Abstract: An ultrasound imaging system transmits a broad beam of ultrasound into tissues that are perfused with blood containing microbubbles. The ultrasound has an intensity that is sufficient to destroy the microbubbles in the tissues. A plurality of ultrasound imaging beams are then transmitted into the tissues over a sufficient period to allow the tissues to re-perfuse, and reflections from the transmitted imaging beams are processed to provide a perfusion image. The transmitted microbubble-destroying ultrasound may be in the form of a single beam or a plurality of beams that insonify a substantially larger area than the area insonified by the transmitted imaging beams. As a result, the microbubbles are all destroyed at substantially the same time, and the imaging ultrasound is transmitted only into regions of the tissues from which ultrasound reflections will be received.
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: July 13, 2010
    Assignee: Koninklijke Philips Electronics, N.V.
    Inventors: Michalakis Averkiou, Patrick G. Rafter
  • Patent number: 7749167
    Abstract: An ultrasonic diagnosis apparatus and method wherein both imaging of a contrast effect and imaging of a tissue appearance before and after inflow of a contrast medium can be realized on condition that low-power transmission and a high frame rate are maintained. The ultrasonic diagnostic apparatus includes a transmission/reception unit for transmitting subject ultrasonic waves with a band substantially centered at a fundamental frequency and generating a received signal based on an ultrasonic echo from the subject, a harmonic unit for extracting a signal of a harmonic component of the fundamental frequency included in the received signal and extracting a signal of the fundamental component with the band substantially centered the fundamental frequency included in the received signal, and a display unit for generating a display image based on the extracted harmonic and fundamental components.
    Type: Grant
    Filed: December 8, 2005
    Date of Patent: July 6, 2010
    Assignee: Kabushiki Kaisha Toshiba
    Inventors: Tetsuya Kawagishi, Yoshitaka Mine, Koichiro Kurita, Masamichi Oyanagi
  • Patent number: 7744532
    Abstract: Ultrasound imaging adapts as a function of a coherence factor. Various beamforming, image forming or image processing parameters are varied as a function of a coherence factor to improve detail resolution, contrast resolution, dynamic range or SNR. For example, a beamforming parameter such as the transmit or receive aperture size, apodization type or delay is selected to provide maximum coherence. Alternatively or additionally, an image forming parameter, such as the number of beams for coherent synthesis or incoherent compounding, is set as a function of the coherence factor. Alternatively or additionally an image processing parameter such as the dynamic range, linear or nonlinear video filter and/or linear or nonlinear map may also adapt as a function of the coherence factor.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: June 29, 2010
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Kutay F. Ustuner, Pai-Chi Li, Meng-Lin Li, Tom L. Thomas, Albert Gee
  • Publication number: 20100145196
    Abstract: An ultrasound imaging method for use in the presence of contrast agents is disclosed in which acoustic waves are transmitted at a fundamental transmission frequency and are focused on at least one scan line. Acoustic beams reflected from the body under examination and the contrast agents are separated into harmonic and subharmonic components along with the fundamental frequency component. The amplitudes of these components compared to determine whether the reflecting material is either body tissue or the contrast agent.
    Type: Application
    Filed: February 10, 2010
    Publication date: June 10, 2010
    Inventor: Marino Cerofolini